COX-2 Mouse Monoclonal Antibody (clone COX 229), Concentrate - Citations

COX-2 Mouse Monoclonal Antibody (clone COX 229), Concentrate - Citations

View additional product information for COX-2 Mouse Monoclonal Antibody (clone COX 229), Concentrate - Citations (187379)

Showing 5 product Citations

Citations & References
Abstract
Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
AuthorsJohnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, Sveinbjörnsson B, Kogner P,
JournalCancer Res
PubMed ID15492235
'Neuroblastoma is the single most common and deadly tumor of childhood and is often associated with therapy resistance. Cyclooxygenases (COXs) catalyze the conversion of arachidonic acid to prostaglandins. COX-2 is up-regulated in several adult epithelial cancers and is linked to proliferation and resistance to apoptosis. We detected COX-2 expression in ... More
Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer.
AuthorsLuo H, Chen Z, Jin H, Zhuang M, Wang T, Su C, Lei Y, Zou J, Zhong B
JournalJ Exp Clin Cancer Res
PubMed ID21219643
'Vascular endothelial growth factor (VEGF) expression is up-regulated via a cyclooxygenase-2 (COX-2)-dependent mechanism in non-small cell lung cancer (NSCLC), but the specific signaling pathway involved is unclear. Our aim was to investigate the signaling pathway that links COX-2 with VEGF up-regulation in NSCLC.' ... More
Correlation between LRIG1 and LRIG2 expressions and expression of 11 tumor markers, with special reference to tumor suppressors, in CIN and normal cervical epithelium.
AuthorsLindström AK, Asplund A, Hellberg D
JournalGynecol Oncol
PubMed ID21632100
Novel biological markers LRIG1 and LRIG2 have been associated with favorable as well as poor prognosis, respectively, in different cancer types, including cervical cancer. The aim of this study was to investigate possible interactions between these proteins and other tumor markers, and as diagnostic adjuncts in CIN. ... More
Correlation of biomarkers in head and neck squamous cell carcinoma.
AuthorsTse GM, King AD, Yu AM, Lam CC, Chan AW, Chen GG, Yeung DK, Yu KH, Bhatia KS, Chan AB
JournalOtolaryngol Head Neck Surg
PubMed ID21109080
To evaluate the relationship of functional magnetic resonance imaging (MRI) parameters, including choline/creatine ratio (Cho/Cr) and apparent diffusion coefficient (ADC) with protein expression of 10 common tumor and prognostic markers in head and neck squamous cell carcinoma. ... More
Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts.
AuthorsShiirevnyamba A, Takahashi T, Shan H, Ogawa H, Yano S, Kanayama H, Izumi K, Uehara H
JournalBr J Cancer
PubMed ID21206493
The interaction between prostate cancer cells and osteoblasts is critical for the development of bone metastasis. Metastatic cancer cells may physically contact osteoblasts in the bone microenvironment; however, the biological significance of this interaction is not fully understood. ... More